Pharmaceutical Glass Packaging Market Report 2026

The pharmaceutical glass packaging market size has grown rapidly in recent years. It will grow from $16.12 billion in 2025 to $17.91 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to growth in pharmaceutical manufacturing, rising demand for secure medicine storage, increasing focus on sterile packaging, early development of reliable medical container systems, expansion of injectable drug usage.

The pharmaceutical glass packaging market size is expected to see rapid growth in the next few years. It will grow to $27.35 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to rising production of biologics, increasing reliance on high integrity packaging, growing regulatory emphasis on medical safety, strengthening need for durable pharmaceutical storage, expanding pharmaceutical distribution networks. Major trends in the forecast period include increasing demand for safe pharmaceutical storage, growing adoption of high quality medical packaging, rising focus on contamination free drug containers, strengthening dependence on temperature stable packaging, increasing use of specialized pharmaceutical glass solutions.

The expansion of the pharmaceutical industry is anticipated to drive the growth of the pharmaceutical glass packaging market in the coming years. The pharmaceutical industry involves the research, development, and production of medicines and drugs. Pharmaceutical glass packaging is widely used for packaging and storing medications, as well as strong alkalis and acids, due to its chemical resistance and stability. For example, in 2023, according to Zippia, a US-based information platform, the US pharmaceutical industry accounted for 43.7% of the global pharmaceutical market. Consequently, the growth of the pharmaceutical industry is contributing to the expansion of the pharmaceutical glass packaging market.

Leading companies operating in the pharmaceutical glass packaging market are concentrating on product innovation, such as the development of glass jars, to gain a competitive advantage. Glass jars are cylindrical or slightly tapered containers made of glass, ceramic, or plastic, featuring a wide opening that can be sealed with a lid, screw cap, or lug cap. For instance, in October 2023, Stoelzle Pharma, an Austria-based pharmaceutical glass packaging company, introduced the PharmaCos packaging line. This product range includes glass jars and bottles in sizes from 5 ml to 500 ml in amber glass with a screw-neck design, along with flat-shoulder bottles ranging from 20 ml to 150 ml. The PharmaCos line is designed as a sustainable packaging option for healthcare products, incorporating high levels of recycled glass content, with 73% recycled material in amber glass and 38% in flint glass.

In August 2025, SGD Pharma, a France-based supplier of pharmaceutical primary packaging solutions such as glass vials, ampoules, and ready-to-use products for injectable drugs and biologics, acquired Alphial S.r.l. for an undisclosed amount. Through this acquisition, SGD Pharma aims to expand its tubular glass conversion capabilities in Europe, strengthen its regional manufacturing presence, and enhance its product portfolio to better serve global pharmaceutical customers with increased capacity and more localized supply chain solutions. Alphial S.r.l. is an Italy-based manufacturer of tubular glass products specializing in ampoules, vials, and ready-to-use glass packaging for the pharmaceutical industry across several European facilities.

Major companies operating in the pharmaceutical glass packaging market report are AGC Inc., Corning Inc., Şişecam, Ardagh Group S.A., O-I Glass Inc., Hoya Corporation, Nipro Corp, Bormioli Pharma SpA, Gerresheimer AG, Wheaton Industries Inc., Shandong Pharmaceutical Glass Co Ltd., Hindusthan National Glass & Industries Limited, Yoshino Glass Co Ltd., Stolzle Glass Group, Schott AG, Beatson Clark, Arab Pharmaceutical Glass Co, Acme Vial & Glass Co, United Glass Company, SGD SA, Yamamura Glass Co Ltd., Toyo Glass Co Ltd., NEG Group Co Ltd.

North America was the largest region in the pharmaceutical glass packaging market in 2025. The regions covered in the pharmaceutical glass packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical glass packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical glass packaging market consists of sales of borosilicate glass, treated soda-lime glass, regular soda-lime glass, and general purpose soda-lime. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.